Hypermarcas (OTCMKTS:HYPMY) Sees Unusually-High Trading Volume – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) shares saw an uptick in trading volume on Tuesday. Approximately 208,413 shares changed hands during mid-day trading, an increase of 629% from the previous session’s volume of 28,608 shares. The stock last traded at $5.4394 and had previously closed at $5.40.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy”.

Get Hypermarcas alerts:

Check Out Our Latest Research Report on Hypermarcas

Hypermarcas Stock Performance

The stock has a market cap of $3.82 billion, a P/E ratio of 10.85 and a beta of 0.65. The stock has a fifty day simple moving average of $4.37 and a 200-day simple moving average of $4.34. The company has a quick ratio of 1.26, a current ratio of 1.86 and a debt-to-equity ratio of 0.50.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a return on equity of 12.68% and a net margin of 19.77%. Equities analysts expect that Hypermarcas will post 0.51 earnings per share for the current fiscal year.

About Hypermarcas

(Get Free Report)

Hypermarcas SA was a Brazilian consumer healthcare company that developed, manufactured and marketed pharmaceutical and healthcare products. Its portfolio included over-the-counter medicines, prescription products, vitamins and other consumer health brands sold through pharmacies and retail channels.

The company was historically associated with well-known Brazilian brands such as Benegrip, Biotônico Fontoura, Doril, Engov and Epocler. Hypermarcas also previously operated in personal care, beauty, household cleaning and other consumer categories, but divested many of those businesses as it concentrated on pharmaceuticals and healthcare.

In 2018, Hypermarcas changed its corporate name to Hypera SA, adopting the Hypera Pharma identity.

Featured Stories

• Five stocks we like better than Hypermarcas
• Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
• Why onsemi’s Synaptics Pivot Could Be a Game Changer
• AI Chip Demand Gives Linde a New Growth Catalyst
• Qualcomm’s Huawei Deal Adds Strategic Depth to Its AI Expansion

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.